Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
abaloparatide parathyroid hormone/parathyroid hormone-related peptide receptor biotech NA drugbank , DGIDB Spinal Fractures[MeSHID:D016103]
Osteoporosis
Postmenopausal[MeSHID:D015663]
Bone structure of spine[MeSHID:D013131]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 14.14 approved,investigational ligand,agonist
abaloparatide parathyroid hormone 1 receptor NA Successful target TTD , DGIDB Spinal Fractures[MeSHID:D016103]
Osteoporosis
Postmenopausal[MeSHID:D015663]
Bone structure of spine[MeSHID:D013131]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 14.14 approved unknown
abaloparatide parathyroid hormone 1 receptor NA Successful target TTD , DGIDB Spinal Fractures[MeSHID:D016103]
Osteoporosis
Postmenopausal[MeSHID:D015663]
Bone structure of spine[MeSHID:D013131]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 14.14 approved agonist
abaloparatide parathyroid hormone/parathyroid hormone-related peptide receptor biotech NA drugbank , DGIDB Spinal Fractures[MeSHID:D016103]
Osteoporosis
Postmenopausal[MeSHID:D015663]
Bone structure of spine[MeSHID:D013131]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 14.14 approved,investigational ligand
click here to return to the previous page